By Barb Martinez, Global Senior Product Manager Custom Cell Culture Media, Damon Talley, Head of Cell Culture Media Quality, Pascal Perrotey, Head of Cell Culture Media Operations
Continued growth of the biopharmaceutical industry, along with the remarkable expansion of new therapies, have increased the demand for cell culture media. As an essential component of upstream processes, the quality of the media, along with continuity of supply, are critical to minimize interruptions in manufacturing. The complexity of media formulations, which contain a variety of raw materials from different sources, can impact consistency and availability unless a robust supply chain and control measures to minimize variability are in place.
In this white paper, we describe the establishment of a robust, global manufacturing network for our cell culture media. This network enables consistent production of high quality media, supports capacity expansion to meet growing demand and provides product comparability for business continuity. This gives you confidence that you are receiving the highest quality and consistency from any of our manufacturing sites around the world.